Kala Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.51-$20.60 |
Market Cap | $18M |
Shares Short | 928,449 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $1.3M |
Diluted EPS | -$5.64 |
News
See moreYahoo Finance • last month
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Yahoo Finance • last month
KALA BIO to raise $10 mln in registered direct offering
Yahoo Finance • last month
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Yahoo Finance • last month
BC-Most Active Stocks
About
CEO | Mr. David Elliot Lazar |
CFO | Mr. David Elliot Lazar |
Address | 1167 Massachusetts Avenue, Arlington, MA, United States, 02476 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |
